In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670
Open Access
- 1 January 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (2) , 405-413
- https://doi.org/10.1111/j.1476-5381.1995.tb13241.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Antihypertensive Actions of the Novel Nonpeptide Endothelin Receptor Antagonist SB 209670Hypertension, 1995
- Endothelin‐1 modulates vascular smooth muscle structure and vasomotion: Implications in cardiovascular pathologyDrug Development Research, 1993
- In Vitro and In Vivo Studies with a Series of Hexapeptide Endothelin AntagonistsJournal of Cardiovascular Pharmacology, 1993
- Comparative Studies with the Endothelin Receptor Antagonists BQ-123 and PD 142893 Indicate At Least Three Endothelin ReceptorsJournal of Cardiovascular Pharmacology, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Venous smooth muscle contains vasoconstrictor ETB-like receptorsBiochemical and Biophysical Research Communications, 1992
- Endothelin and structurally related analogs distinguish between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1992
- Regional Hemodynamic Effects of Endothelin-1 in Conscious, Unrestrained, Wistar RatsJournal of Cardiovascular Pharmacology, 1989
- Studies with Endothelin-3 and Endothelin-1 on Rat Blood Pressure and Isolated TissuesJournal of Cardiovascular Pharmacology, 1989
- Pressor Effects of Endothelin-1 and Some Analogs in the Perfused Superior Mesenteric Arterial Bed of the RatJournal of Cardiovascular Pharmacology, 1989